6 results
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI) Pathophysiology ... Tuberculosis: • Endogenous ... characteristic features Clinical ... Tuberculosis Treatment ... #ActiveTB #LatentTB
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI) Pathophysiology ... Tuberculosis: • Endogenous ... characteristic features Clinical ... Tuberculosis Treatment ... #ActiveTB #LatentTB
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
Risk factors: Critical ... without other cause ... : 33% • Treatment ... Transfusion #Reactions #hematology ... diagnosis #comparison #table
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
salivary ducts Clinical ... Nephrogenic DI Hematologic ... Adenocarcinoma Treatment ... lubricants • Pharmacologic ... muscarinic agonists • Active
Trigger Finger - Stenosing flexor tendon tenosynovitis

There is a change in the slip between the tendon
to perform active ... The diagnosis is clinical ... of non-surgical treatment ... Treatment can be ... #orthopedics #rheumatology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
no evidence of active ... for active or latent ... HIV-infected persons with clinical ... Please refer to the table ... infections #HIVAIDS #pharmacology